Current Pharmaceutical Therapies for Meibomian Gland Dysfunction: From Basic Research to Clinical Practice

Documenti analoghi

• Association of Eyelid Margin Thickness and Meibography in Dogs With Meibomian Gland Dysfunction
  di: Giyeon Kim, et al.
  Pubblicazione: (2025)
• Australia's Rising Rates of Intravitreal Injections: Forecasting the Demand for Intravitreal Injections in Australia Using Data From the Pharmaceutical Benefits Scheme
  di: Emma Tovey Crutchfield, et al.
  Pubblicazione: (2026)
• Drug‐associated glaucoma: A real‐world study based on the Food and Drug Administration adverse event reporting system database
  di: Shi‐Nan Wu, et al.
  Pubblicazione: (2024)
• Orbital Rhabdomyosarcoma: A Comprehensive Review of Clinical Features, Molecular Advances and Current Management
  di: Kamil Gabriël Laban, et al.
  Pubblicazione: (2026)
• Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry
  di: Carla Gaggiano, et al.
  Pubblicazione: (2025)